News

Sitting time linked to NAFLD

View on the News

Our chairs are killing us

The findings of Ryu et al. add to the strong and alarming evidence that sitting too much and moving too little have significant negative consequences for cardiometabolic health.

Our bodies are designed to move, so it shouldn’t be surprising that sedentary behavior has a direct impact on physiology. The adverse effects on our cardiovascular and respiratory systems have been well studied, but the impact on the liver has not. This is a promising area for future research.

Meanwhile, this study’s message is clear: Our chairs are slowly but surely killing us.

Dr. Michael I. Trenell is professor of metabolism and lifestyle medicine at the Institute of Cellular Medicine, Newcastle (England) University. He is supported by the U.K. National Institute for Health Research and the National Institute for Health Research Biomedical Research Centre for Ageing and Age-Related Disease. Dr. Trenell reported having no relevant financial disclosures. He made these remarks in an editorial accompanying Dr. Ryu’s report.


 

FROM JOURNAL OF HEPATOLOGY

References

The more time middle-aged men and women spend sitting, the greater the likelihood they will show nonalcoholic fatty liver disease on ultrasonography at an annual physical examination, according to a report published online.

While this association may not be surprising, the fact that it remained robust regardless of an individual’s level of exercise and independent of his or her body mass index (BMI) was unexpected. Even adults with a BMI less than 23 kg/m2 and even those who exercised vigorously several times per week were more likely to develop nonalcoholic fatty liver disease (NAFLD) if they spent a substantial part of their day sitting down. So it appears that both increasing physical activity and reducing sitting time are important in reducing NAFLD risk, said Seungho Ryu, M.D., of the department of occupational and environmental medicine, Kangbuk Samsung Hospital, Seoul, and associates.

The investigators discovered the association between sitting and NAFLD in a large observational cohort study involving 72,914 Korean men and 66,142 Korean women undergoing routine annual physical examinations at two academic clinics during a 2-year period. These study participants (mean age, 39.9 years) answered questionnaires regarding the average time they spent sitting at work, home, and leisure, as well as their usual dietary intake and typical level of physical activity.

©Erik Snyder/thinkstockphotos.com

Sitting time was positively associated with the prevalence of NAFLD, independently of physical activity level. The prevalence ratios for the disorder were 1.05 for sitting 5-9 hr/day and 1.12 for sitting 10 hr/day or more, compared with the reference category of sitting for fewer than 5 hr/day. And the prevalence of NAFLD rose in a linear fashion with increased sitting time across all categories of physical activity, Dr. Ryu and associates said (J. Hepatol. 2015 Sep 15 [doi: 10.1016/j.hep.2015.07.010]).

The mechanism underlying this association is not yet known. A causal relationship cannot be assumed on the basis of these findings because this was a cross-sectional observational study, not a longitudinal or prospective randomized study. However, it seems reasonable that in real-world practice, replacing periods of sitting with periods of standing and light activity would be helpful to reduce the risk of NAFLD, they added.

The investigators noted that these study participants were all Korean, were well educated, and attended health examinations regularly, so the study results may not be generalizable to other populations with different demographic profiles.

The sources of funding for this study weren’t identified. Dr. Ryu and associates reported having no relevant financial disclosures.

Recommended Reading

VIDEO: Does childhood abdominal pain portend adult GI problems?
MDedge Internal Medicine
Hepatitis E linked to 1 in 10 liver failure cases in Europe
MDedge Internal Medicine
Reference payment plan cuts colonoscopy costs by 20%
MDedge Internal Medicine
Integrated care overcomes HCV treatment barriers
MDedge Internal Medicine
Symptom-based diagnostic criteria: A work in progress in IBS
MDedge Internal Medicine
Smartphone app can pick up covert hepatic encephalopathy
MDedge Internal Medicine
Uncorking the negative emotions of IBS
MDedge Internal Medicine
Methotrexate ups risk of liver abnormalities, but not serious hepatic events
MDedge Internal Medicine
Sofosbuvir-velpatasvir combo effective in all HCV genotypes
MDedge Internal Medicine
Readmissions for C. difficile infections high among elderly
MDedge Internal Medicine